DMD is a devastatingly progressive muscle wasting disorder of childhood that significantly shortens life expectancy. Despite efforts to develop an effective therapy that dates back over a century, clinical interventions are still restricted to management of symptoms rather than a cure. The rationale to develop effective therapies changed in 1986 with the discovery of the dystrophin gene. Since then extensive research into both the molecular basis and pathophysiology of DMD has paved the way n...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record